.Nature Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for incorporation of people with MASLD and also dimension of liver end results in cardio-- kidney-- metabolic trials, when information suggest mechanistically tenable benefits and also scientific protection-- and also outlines factors for trial design and also governing commendation.